Caribou Biosciences Inc [NASDAQ: CRBU] stock went on an upward path that rose over 28.17% on Tuesday, amounting to a one-week price increase of more than 68.52%.
Over the last 12 months, CRBU stock dropped by -56.67%. The one-year Caribou Biosciences Inc stock forecast points to a potential upside of 82.94. The average equity rating for CRBU stock is currently 1.44, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $246.57 million, with 88.45 million shares outstanding and 79.88 million shares in the current float. Compared to the average trading volume of 2.40M shares, CRBU stock reached a trading volume of 10120452 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Caribou Biosciences Inc [CRBU]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CRBU shares is $16.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CRBU stock is a recommendation set at 1.44. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Evercore ISI have made an estimate for Caribou Biosciences Inc shares, keeping their opinion on the stock as In-line, with their previous recommendation back on June 03, 2024. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Neutral. The new note on the price target was released on November 08, 2023, representing the official price target for Caribou Biosciences Inc stock. Previously, the target price had yet another raise to $13, while Evercore ISI analysts kept a Outperform rating on CRBU stock.
The Average True Range (ATR) for Caribou Biosciences Inc is set at 0.20, with the Price to Sales ratio for CRBU stock in the period of the last 12 months amounting to 7.38. The Price to Book ratio for the last quarter was 0.72, with the Price to Cash per share for the same quarter was set at 3.25.
CRBU Stock Performance Analysis:
Caribou Biosciences Inc [CRBU] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 68.52. With this latest performance, CRBU shares gained by 41.45% in over the last four-week period, additionally sinking by -49.77% over the last 6 months – not to mention a drop of -56.67% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CRBU stock in for the last two-week period is set at 72.26, with the RSI for the last a single of trading hit 85.33, and the three-weeks RSI is set at 61.02 for Caribou Biosciences Inc [CRBU]. The present Moving Average for the last 50 days of trading for this stock 2.45, while it was recorded at 2.09 for the last single week of trading, and 4.59 for the last 200 days.
Insight into Caribou Biosciences Inc Fundamentals:
Caribou Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.49 and a Current Ratio set at 10.49.
CRBU Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CRBU. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Caribou Biosciences Inc go to 14.50%.
Caribou Biosciences Inc [CRBU] Institutonal Ownership Details
The top three institutional holders of CRBU stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in CRBU stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in CRBU stock with ownership which is approximately 5.1238%.
